Ulises Novoa

611 total citations
21 papers, 460 citations indexed

About

Ulises Novoa is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Ulises Novoa has authored 21 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Ulises Novoa's work include Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (8 papers) and Apelin-related biomedical research (6 papers). Ulises Novoa is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (8 papers) and Apelin-related biomedical research (6 papers). Ulises Novoa collaborates with scholars based in Chile, United States and Germany. Ulises Novoa's co-authors include María Paz Ocaranza, Jorge Jalil, Mario Chiong, Sergio Lavandero, Iván Godoy, Leticia González, Lorena Garcı́a, Carlos D. Figueroa, Luigi Gabrielli and Werner Müller‐Esterl and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Ulises Novoa

20 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulises Novoa Chile 11 249 178 139 60 55 21 460
Atsushi Shiota Japan 9 368 1.5× 115 0.6× 192 1.4× 95 1.6× 41 0.7× 13 546
Franziska Rompe Germany 6 247 1.0× 161 0.9× 141 1.0× 47 0.8× 42 0.8× 6 400
Lívia Corrêa Barroso Brazil 9 207 0.8× 178 1.0× 87 0.6× 61 1.0× 51 0.9× 10 512
Che Ping Cheng United States 12 254 1.0× 159 0.9× 89 0.6× 29 0.5× 49 0.9× 28 419
Jiqian Huang United States 10 412 1.7× 234 1.3× 360 2.6× 73 1.2× 33 0.6× 15 598
M F Gonzales France 6 399 1.6× 109 0.6× 259 1.9× 98 1.6× 22 0.4× 6 536
Ane Cláudia Fernandes Nunes United States 13 174 0.7× 127 0.7× 87 0.6× 24 0.4× 90 1.6× 25 546
Sha Guan United States 6 249 1.0× 146 0.8× 188 1.4× 31 0.5× 66 1.2× 6 451
Maurice E. Fabiani Australia 8 230 0.9× 109 0.6× 172 1.2× 35 0.6× 41 0.7× 8 402
Atsuko Fujiyama Japan 5 424 1.7× 178 1.0× 285 2.1× 87 1.4× 41 0.7× 5 534

Countries citing papers authored by Ulises Novoa

Since Specialization
Citations

This map shows the geographic impact of Ulises Novoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulises Novoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulises Novoa more than expected).

Fields of papers citing papers by Ulises Novoa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulises Novoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulises Novoa. The network helps show where Ulises Novoa may publish in the future.

Co-authorship network of co-authors of Ulises Novoa

This figure shows the co-authorship network connecting the top 25 collaborators of Ulises Novoa. A scholar is included among the top collaborators of Ulises Novoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulises Novoa. Ulises Novoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mondaca‐Ruff, David, et al.. (2021). Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension. Journal of Cardiovascular Pharmacology and Therapeutics. 26(6). 724–735. 5 indexed citations
3.
Norambuena‐Soto, Ignacio, María Paz Ocaranza, Fernanda Sanhueza‐Olivares, et al.. (2020). Angiotensin-(1–9) prevents vascular remodeling by decreasing vascular smooth muscle cell dedifferentiation through a FoxO1-dependent mechanism. Biochemical Pharmacology. 180. 114190–114190. 13 indexed citations
4.
Jalil, Jorge, Ulises Novoa, Iván Godoy, et al.. (2019). Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients. Current Vascular Pharmacology. 18(1). 87–91. 3 indexed citations
5.
González, Leticia, Ulises Novoa, Luigi Gabrielli, et al.. (2018). Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension. Biochemical Pharmacology. 156. 357–370. 36 indexed citations
6.
Novoa, Ulises, Diego Arauna, Sebastián Zagmutt, et al.. (2017). High‐Intensity Exercise Reduces Cardiac Fibrosis and Hypertrophy but Does Not Restore the Nitroso‐Redox Imbalance in Diabetic Cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2017(1). 7921363–7921363. 52 indexed citations
7.
Novoa, Ulises, et al.. (2016). Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels. International Journal of Cardiology. 215. 309–317. 14 indexed citations
8.
Jalil, Jorge, et al.. (2016). Diuretics prevent Rho-kinase activation and expression of profibrotic/oxidative genes in the hypertensive aortic wall. Therapeutic Advances in Cardiovascular Disease. 10(6). 338–347. 8 indexed citations
9.
Ocaranza, María Paz, Víctor Barrientos, Rodrigo Alzamora, et al.. (2014). Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. Journal of Hypertension. 32(4). 771–783. 74 indexed citations
10.
Gabrielli, Luigi, Iván Godoy, Samuel Córdova, et al.. (2013). Increased Rho-Kinase Activity in Hypertensive Patients With Left Ventricular Hypertrophy. American Journal of Hypertension. 27(6). 838–845. 32 indexed citations
11.
Pereira, Jaime, Claudia G. Sáez, Julio Pallavicini, et al.. (2012). Cocaine-Induced Endothelial Dysfunction: Role of RhoA/Rho Kinase Pathway Activation.. Blood. 120(21). 2177–2177. 4 indexed citations
12.
Novoa, Ulises, Iván Godoy, Mario Chiong, et al.. (2012). Mayores niveles de ECA y Angiotensina II determinados genéticamente, se asocian a menor actividad del eje ECA2/angiotensina-(1-9) y mayor remodelamiento de la pared aórtica de ratas hipertensas. Revista chilena de cardiología. 31(2). 118–128. 1 indexed citations
13.
Ocaranza, María Paz, Luigi Gabrielli, Lorena Garcı́a, et al.. (2011). Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure. American Heart Journal. 161(5). 931–937. 31 indexed citations
14.
Ocaranza, María Paz, Ulises Novoa, Leticia González, et al.. (2011). Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension. Journal of Hypertension. 29(4). 706–715. 48 indexed citations
15.
Gabrielli, Luigi, Jorge Jalil, Iván Godoy, et al.. (2010). RHO-KINASE ACTIVITY IS INCREASED IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY.. Journal of the American College of Cardiology. 55(10). A60.E577–A60.E577.
16.
Ocaranza, María Paz, Sergio Lavandero, Jorge Jalil, et al.. (2010). Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro. Journal of Hypertension. 28(5). 1054–1064. 75 indexed citations
17.
18.
Figueroa, Carlos D., Ulises Novoa, Ulrich Förstermann, et al.. (2001). Differential Distribution of Bradykinin B2Receptors in the Rat and Human Cardiovascular System. Hypertension. 37(1). 110–120. 42 indexed citations
19.
Figueroa, Carlos D., Ulises Novoa, Gloría Valdés, Jenny Corthorn, & Werner Müller‐Esterl. (1997). Localization of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells. Immunopharmacology. 36(2-3). 127–133. 10 indexed citations
20.
Figueroa, Carlos D., et al.. (1996). Rat bradykinin B2 receptor: Immunochemical characterization and immunovizualization in epithelial and smooth muscle cells. Immunopharmacology. 33(1-3). 85–89. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Shiota Breakdown of academic impact, for papers by Franziska Rompe Breakdown of academic impact, for papers by Lívia Corrêa Barroso Breakdown of academic impact, for papers by Che Ping Cheng Breakdown of academic impact, for papers by Jiqian Huang Breakdown of academic impact, for papers by M F Gonzales Breakdown of academic impact, for papers by Ane Cláudia Fernandes Nunes Breakdown of academic impact, for papers by Sha Guan Breakdown of academic impact, for papers by Maurice E. Fabiani Breakdown of academic impact, for papers by Atsuko Fujiyama
Rankless by CCL
2026